Ingredients / Emerging

The production methodology defines the ingredient’s core identity.

Two protein concentrates can feature an identical amino acid profile yet share almost no other physical or functional attributes. They are separated fundamentally by their manufacturing history. The underlying production methodology dictates the operational reality of what you are onboarding: the regulatory compliance status, the mechanical processing behavior, and the maturity of the supporting supply chain.

Photograph: cottonbro studio

The short version

The Tri-Axe Trade-Off: Performance metrics, clean-label positioning, and environmental sustainability naturally pull in opposite directions. Product development teams must manage these multi-variable trade-offs rather than assuming a single optimization lane exists.
Fermentation Diversity: Industrial fermentation comprises six independent production pathways utilizing distinct organisms, yielding different target molecules, carrying disparate capital costs, and operating under separate regulatory frameworks.
Upcycling vs. Green-Field Supply Chains: Upcycled inputs leverage existing agricultural infrastructure and mature raw material supply chains. Conversely, emerging novel ingredients frequently require entirely new processing technologies and supply chains that remain in early stages of development.
The Documentation Bottleneck: The primary limiting constraint for novel proteins is rarely the underlying technology. The critical bottleneck is regulatory documentation: species-specific feeding trials, toxicology reports, and formal letters of no objection that cover your exact target species, life stage, and legal jurisdiction.
Postbiotic Thermal Resilience: Postbiotics do not rely on keeping a live microorganism viable, yielding a distinct stability profile compared to probiotics during high-heat processing. This resilience represents a strict manufacturing advantage, not an indicator of superior clinical efficacy.
Extrusion Rheology Alterations: When a novel protein replaces a carbohydrate or starch fraction within a recipe, it completely alters the extrusion melt behavior. This mechanical consequence can fundamentally reshape the entire reformulation strategy.

Evidence Standard

To maintain technical transparency, we explicitly index the empirical validity of all scientific and performance claims across our portfolio:

PublishedPeer-reviewed, species-specific data published within an indexed scientific journal carrying a valid DOI. We conduct a full-text review of every cited paper.

EstablishedWidely accepted principles in animal nutrition science supported by decades of convergent empirical evidence across species.

Context-dependentData that apply only under defined conditions—including species, life stage, processing method, and inclusion rate—where context dictates the operational outcome.

Technical viewOur commercial and technical assessment, informed by published evidence and direct supply chain observations. This represents technical opinion, not established science.

Evidence gapCritical operational domains where published, species-specific data is thin or absent, defining the current boundaries of the technical file.

Why they matter

Critical Evaluation: Three Pillars on One Trade-Off Surface

Evaluating emerging ingredients requires balancing three competing operational priorities. Optimizing a formulation for any single pillar mandates an intentional, calculated adjustment of the remaining two parameters.

A novel ingredient candidate must be audited against the entire multi-variable surface, never evaluated against a single isolated parameter. Technical view

What they are

Six Production Pathways under a Unified Nomenclature

While the term “fermentation” is frequently utilized as a singular label on consumer packaging, it encompasses six entirely independent manufacturing pathways. Each distinct processing route relies on specialized organisms, generates unique molecular outputs, and carries a distinct financial and capital profile.

Route	What You Are Buying	What Comes Attached
Single-cell protein biomass	Whole, dehydrated microbial cells cultivated on a targeted carbon feedstock. The microbial organism itself constitutes the finished product.	Intact cell-wall fractions—specifically beta-glucans and functional nucleotides—are natively embedded throughout the protein matrix.
Mycoprotein fungal biomass	Filamentous fungal biomass featuring a physical structure that is distinct from traditional yeast-derived options, engineered for somatosensory texture and nutritional density.	Elevated structural fiber concentrations require precise formulation management, and ribonucleic acid (RNA) reduction remains a core processing milestone.
Precision fermentation engineered host	Specific, hyper-targeted functional molecules—including pure proteins, specialized lipids, or catalytic enzymes—synthesized by a genetically engineered host organism.	Downstream purification and separation protocols dictate finished product purity and total cost-in-use. The specific output molecule dictates the regulatory approval pathway.
Insect protein larval biomass	Whole-organism insect tissues processed mechanically into dehydrated larvae, defatted protein meals, or clean lipid/oil fractions.	Chitin is natively present within the structural matrix, lipid profiles fluctuate by lot, and the complete amino acid spectrum differs from traditional vertebrate proteins.
Algal biomass	Whole-cell dried formats or refined, extracted fractions, with docosahexaenoic acid (DHA)-rich lipid oils representing the primary commercial application.	Native iodine and heavy-metal concentrations fluctuate based on localized aquatic growing conditions, and mechanical cell-wall disruption directly alters finished product bioavailability.
Postbiotics	Mechanically inactivated microbial cell structures combined with their functional, soluble fermentation metabolites, requiring zero biological viability through the bowl.	Processing thermal stability can be evaluated completely independent of live-organism viability constraints, backed by a rapidly expanding empirical clinical file.

Strategic Infrastructure Analysis: Upcycling vs. Green-Field Operations

Upcycled System Solutions: These processes transform pre-existing agricultural side-streams and secondary co-products into high-value functional inputs. They operate entirely within established corporate logistics infrastructure, utilize readily available and predictable raw material volumes, and navigate recognized, well-defined regulatory approval pathways.

Emerging Ingredient Systems: These inputs mandate the commercialization of novel, green-field production technologies and unproven, developing supply networks. They require extensive, original documentation dossiers to secure formal regulatory clearance across specific companion animal species, life stages, and trade jurisdictions. Furthermore, executing a rollout with these novel materials requires technical validation of upstream supply chains that may still be undergoing initial commercial scaling.

The science

Four Distinct Physical and Metabolic Impacts of Alternative Proteins

Substituting a conventional protein source with a novel alternative alters four independent formulation vectors. While the primary physical and mechanical challenges manifest during high-heat extrusion processing, feline metabolic constraints demand absolute nutritional precision.

1. Alteration of the Lysine Damage Profile

Reactive lysine represents the actual amino acid fraction that remains bioavailable to the animal after processing, as high-heat extrusion degrades this nutrient. A comprehensive survey of 67 commercial products demonstrated that individual extruded foods returned reactive-to-total-lysine ratios below 0.70, indicating that over 30% of the analytically measured lysine was chemically damaged during thermal manufacturing, rendering it functionally unavailable to the animal. The ratio between reactive and total lysine establishes the true nutritional return on your ingredient investment.

van Rooijen et al., Journal of Nutritional Science. 67-product survey. Published

2. Displacement of Functional Starch Fractions

Introducing an alternative protein concentrate requires a corresponding removal of dietary starch, which directly modifies Specific Mechanical Energy (SME) requirements, radial expansion, and kibble bulk density. In a production line trial evaluating torula yeast single-cell protein against conventional protein inputs, formulas containing the single-cell protein demanded significantly higher specific mechanical energy: 187 kJ/kg for torula and soybean meal matrices, compared to 138 kJ/kg for pea protein and 167 kJ/kg for chicken meal. This mechanical shift resulted in distinct finished kibble diameters, piece volumes, and sectional expansion ratios.

Holt and Aldrich, Journal of Animal Science, 2022. Feline extruded diets. Published

3. Shifts in the Target Amino Acid Profile

Canine formulations tolerate a relatively broad amino acid variance, whereas feline physiology requires strict adherence to narrow metabolic thresholds. Acute arginine deficiency in felines can induce hyperammonemia and clinical toxicity within hours, while chronic taurine deficiency causes dilated cardiomyopathy and retinal degeneration over extended periods. Swapping protein blocks within a feline formulation mandates a precise recalculation of arginine and taurine inputs to prevent immediate metabolic deficits.

Established

4. Invalidation of Sweetness-Mediated Palatability Mechanisms

Felines lack a functional sweet taste receptor due to the evolutionary pseudogenization of the Tas1r2 gene. This genetic profile dictates that sweetness-mediated palatability mechanisms utilized in human or canine product design yield zero functional results in feline formulas. If an emerging ingredient relies on sensory sweetness to drive voluntary intake, that specific mechanism is entirely ineffective in the feline market segment.

Li et al., PLOS Genetics, 2005. Feline sweet-receptor pseudogene. Published

Evaluating the Technical File Maturity of Emerging Categories

A rigorous technical assessment of the available data dossiers isolates varying tiers of empirical validity across the alternative protein sector

Technical view

Fungal hyphae and spores under a microscope — **Filamentous fungal biomass under magnification.** The hyphal structure is why mycoprotein arrives fibrous rather than powdery, and why it contributes texture that a yeast biomass does not. Photograph: Malik Lafi.

Single-Cell and Fungal Proteins: The Best-Evidenced Emerging Category

Torula yeast single-cell protein possesses the most complete and rigorous extrusion dataset currently available for any alternative protein source in companion animal nutrition. The Holt and Aldrich (2022) trial evaluated specific mechanical energy, radial expansion, bulk density, and finished kibble geometry across multiple formulations, providing vital process-level data that most novel proteins lack entirely.

A separate 2026 study of a Paecilomyces variotii-derived single-cell protein in adult dogs reported apparent total tract digestibility of crude protein at 83.9% and dry matter at 64.3% at 4 to 8% inclusion rates. This evaluation documented no statistically significant difference in palatability compared to the control diet, while identifying measurable shifts in fecal butyrate, propionate, and indigenous microbial populations.

Published

Precision Fermentation: Strong Safety Validation, Limited Processing Data

The strongest published dataset in this category is a 182-day feeding study evaluating 40 dogs across three distinct inclusion levels (15%, 30%, 40% of diet), supported by a separate 24-dog digestibility arm. The study concluded that the engineered ingredient was safe at the inclusion levels evaluated; however, this paper does not define a maximum inclusion threshold for commercial finished food formulations.

What the category still lacks is a comparable, independent body of process-level extrusion data. While establishing safety is a mandatory baseline for a product development team, it does not answer the operational question of how the ingredient behaves when subjected to thermal processing stress.

French et al., Animals, 2025. 40 dogs, 182 days. Published

Insect Protein: The Jurisdictional Question Precedes Nutritional Evaluation

The regulatory compliance landscape for insect-derived protein in pet food is heavily fragmented by geographic jurisdiction, target species, and finished product format. In select markets, insect protein is fully approved for companion animal diets but strictly prohibited in livestock feeds. In other regions, specific insect species are legally permitted while alternative species remain under active administrative review.

For a formulator, the initial question is not whether insect protein delivers a viable nutritional profile, but whether the specific insect species is legally permitted in the specific format for the specific target market. This remains a strict regulatory compliance task rather than an exercise in animal nutrition, and the legal parameters change frequently.

Context-dependent

Technical Due Diligence

Strategic Sourcing Framework: Technical Integration Diagnostics

With an alternative or emerging ingredient, complex formulation bottlenecks typically manifest during or immediately following initial pilot production runs—a stage where an overlooked engineering detail can introduce extreme operational costs. These eight technical questions isolate and address the primary integration and supply chain risks:

Verifying a supplier’s precise regulatory status with official documentation is a critical first step. Reviewing the explicit text of the regulatory letter ensures the approval matches your exact application parameters. Technical view

Regulatory Dossier Scope & Jurisdictional BoundariesVerify that the target animal species, specific life stage, maximum inclusion ceiling, and geographic trade jurisdiction are explicitly authorized in official, written documentation. Administrative approval letters covering adult canine formats do not extend to feline pediatric formulations, and authorizations granted for a 5% inclusion rate do not legally permit a 15% formulation payload.

Ingredient Declaration & Regulatory Nomenclature ComplianceThe official ingredient nomenclature required on consumer packaging frequently differs from the commercial invoice name used in purchasing. Technical directors must align this packaging nomenclature with corporate legal, marketing, and regulatory compliance teams prior to generating final consumer packaging artwork.

Manufacturing Node Integration and Processing PlacementIdentify the exact spatial node where the input is introduced onto the line (e.g., in-barrel dry premix inclusion, post-dryer topical coating enrobing, or wet-side retort blending). This introduction point determines whether thermal and mechanical stability must be managed via plant process parameters or secured by the ingredient producer’s internal manufacturing specifications.

Digestibility Assay Methodologies and Analytical Control BaselinesCanine and feline digestive assays are not interchangeable, and the specific control comparator used defines the true validity of the nutritional claim. For whole-organism or cellular materials, technical teams must verify whether the analytical methods utilized properly accounted for nitrogen bound within complex cell walls or structural chitin, as generic assays can skew whole-organism data if specific conditions are omitted.

Palatability Methodology and Sensory Ingestion MetricsTwo-bowl preference trials and single-bowl acceptance tests evaluate entirely different aspects of animal ingestion behavior. Initial consumption driven by ingredient novelty does not equate to long-term palatability preference; consequently, product development teams must track voluntary intake across repeated, long-term exposure phases.

Extrusion Rheology, Radial Expansion, and Finished Kibble GeometryDisplacing native starches with novel protein concentrates alters Specific Mechanical Energy (SME) requirements, volumetric expansion, and bulk density. These physical shifts occur dynamically inside the extruder barrel and must be stabilized under production line parameters before final palatability metrics are locked.

Amino Acid Profiling and Immutable Metabolic ConstraintsFeline formulations demand absolute, zero-tolerance precision regarding essential amino acids. Technical teams must re-evaluate total dietary arginine and taurine levels after every protein substitution, regardless of how minor the inclusion shift appears on the batch sheet.

Supply Chain Security and Scaled Tonnage ValidationRelying on a single manufacturing facility, a single feedstock supplier, or a supply queue with high-volume human-grade customers ahead of you represents a structural bottleneck. Procurement must verify total annual scaled tonnage, secondary backup manufacturing facilities, and current commercial adoption metrics.

Evaluating digestibility methodology is a critical step, as whole-organism data can be skewed by generic assays if the specific testing conditions are omitted.

Market Trajectory

Four Structural Shifts to Formulate Against

The following vectors represent our professional assessment of where the alternative ingredient sector is moving, drawn from emerging manufacturer requests and peer-reviewed empirical evidence. Each shift raises the baseline proof required by a product development team.

Front-Line Commercial Validation

Scientific evaluation is shifting away from back-office R&D archives into the consumer domain. Empirical proof, data validation, and measurable physiological outcomes are now primary marketing requirements, replacing generic premium stories.

Pre-Digested Nutritional Design

Processing format and raw material functionality are converging. Liquid, fresh, and functional delivery systems are pushing toward a single engineering goal: accelerated absorption and reduced endogenous digestive load are now core product design targets rather than minor side benefits.

Precision-Governed Claim Constraints

Formulation claims are facing rigorous scrutiny from regulatory, scientific, and competitive channels concurrently. An ingredient’s packaging claims must hold up to intense legal and competitive review; the weakest of these three vectors defines the absolute boundary of your marketing freedom.

Side-Stream Output Optimization

Total manufacturing and physiological system outputs are now evaluated, extending beyond simple packaging sustainability. Formulations are increasingly judged on what leaves the animal as well as what enters the bowl. Stool consistency and quality have become primary metrics of premium performance because they provide a highly visible, measurable output that an owner can evaluate without laboratory equipment.

The ingredients that gain lasting traction will be the ones that can be measured, in the target species, on an outcome a customer can see. That is a higher bar than novelty.

Technical view

Technical Co-Creation

Technical Co-Creation and Dossier Audit

Emerging alternative ingredients must be systematically audited across four distinct dimensions of the technical file: physical processing behavior, regulatory compliance positioning, upstream supply chain security, and empirical clinical science. This cross-functional framework synthesizes those criteria into a singular integration plan. This model does not constitute a generic product recommendation; where independent scientific data is thin, that technical file gap is explicitly declared.

If your brand is currently screening a novel or alternative ingredient candidate, our applications team will audit the technical file with your product development directors. We help verify whether the material represents a genuinely new production pathway or a familiar agricultural co-product wrapped in a novel marketing narrative—providing a rapid, data-driven route to validation before you commit capital to an industrial line trial.

Let’s discuss your project

Tell us the format, the process, and where the formula sits today. We will come back with options that fit the product you are making.

Talk to us

Sources

Open access or freely readable without a login. Where a statement is our commercial and technical assessment, it is marked as such on the page.

Holt, D. A. and Aldrich, C. G. (2022). “Evaluation of Torula yeast as a protein source in extruded feline diets.” Journal of Animal Science 100(12), skac327. Establishes processing specific mechanical energy baselines and downstream physical piece dimensions.
Souza, R. B. M. S. de et al. (2026). “Effects of a single-cell protein source from Paecilomyces variotii on diet digestibility and palatability and intestinal functionality of adult dogs.” Frontiers in Veterinary Science 13, 1787800. Quantifies canine apparent total tract digestibility metrics and maps fecal volatile fatty acid shifts at 4% to 8% inclusion.
French, S. et al. (2025). Animals 15(3), 427. Identifies 182-day clinical safety parameters across 40 dogs; confirms the current absence of maximum commercial finished-diet inclusion boundaries.
van Rooijen, C. et al. Reactive and total lysine in commercial pet foods, Journal of Nutritional Science. Open access, PMC4473178. Structural 67-product multi-brand audit establishing that high-heat extrusion reduces reactive-to-total lysine ratios below 0.70.
Li, X. et al. (2005). “Pseudogenization of a sweet-receptor gene accounts for cats’ indifference toward sugar.” PLOS Genetics 1(1):e3. Establishes the molecular micro-deletion within exon three of the feline Tas1r2 gene.
Established comparative nutrition for feline dietary essentials and for feline umami perception via purine nucleotides.

Let’s discuss your project.

Tell us what you are making and where it is going wrong. We will come back with something specific.

Talk to us